Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with AMGN as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|11.04%||Market Vectors Biotech ETF (BBH)||+16.30 (13.72%)|
|6.86%||iShares Nasdaq Biotechnology Index Fund (IBB)||+56.94 (18.17%)|
|5.05%||PowerShares Dynamic Pharmaceuticals (PJP)||+7.02 (9.81%)|
|4.93%||PowerShares Dynamic Biotech &Genome (PBE)||+6.41 (12.51%)|
|4.4%||SPDR Select Sector Fund - Health Care (XLV)||+5.88 (8.53%)|
Company Description (as filed with the SEC)
Amgen Inc. (including its subsidiaries, referred to as "Amgen," "the Company," "we," "our" or "us") is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen was incorporated in California in 1980 and became a Delaware corporation in 1987. ... More ...
Where does AMGN fit in the risk graph?
|Annual EPS Est:||$8.68|
|Quarterly EPS Est:||2.43|